BKM120 (NVP-BKM120, Buparlisib)是一种选择性PI3K抑制,作用于p110α/β/δ/γ时,IC50分别为52 nM/166 nM/116 nM/262 nM,对VPS34, mTOR, DNAPK作用效果降低,对PI4Kβ几乎没有抑制活性。Phase 2。 A PI 3-kinase family inhibitor BKM120 is a selective PI3K inhibitor of p110α/β/δ/γ with IC50 of 52 nM/166 nM/116 nM/262 nM, respectively. Reduced potency against VPS34, mTOR, DNAPK, with little activity to PI4Kβ. Phase 2. A PI 3-kinase family inhibitor
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
BKM120
Dangerous GoodsCAS number:944396-07-0 molecular formula:C18H21F3N6O2
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | AC-35575 | CHEBI:71954 | GTPL7878 | BUPARLISIB [WHO-DD] | AM85983 | HMS3295I15 | SCHEMBL823947 | BKM120,NVP-BKM120 | 3qdd | 5-[2,6-Di(Morpholin-4-Yl)pyrimidin-4-Yl]-4-(Trifluoromethyl)pyridin-2-Amine | BKM 120 | Buparlisib [INN] | 5-(2,6-di-4-morpholinyl- | ||
| CAS number | 944396-07-0 | molecular formula | C18H21F3N6O2 |
| molecular weight | 410.4 g/mol | Exact mass | - |
| PSA | 89.600 Ų | logp | 1.5 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
pictogram:
GHS06 , GHS08
Signal word:
Danger
Hazard Statement:
H301: 吞咽会中毒 H341: 怀疑引起遗传缺陷 H372: 通过长时间或反复暴露对器官造成损害
Statement of Preventive Measures:
P321: 特殊处理(请参阅此标签上的...)。 P405: 密闭存放 P501: 将内容物/容器处理到。。。 P264: 处理后要彻底洗手。 P260: 不要吸入灰尘/烟雾/气体/雾/蒸汽/喷雾。 P281: 根据需要使用个人防护设备。 P270: 使用本产品时,请勿进食、饮水或吸烟。 P330: 漱口 P203: 使用前,获取、阅读并遵守所有安全说明。 P301+P316: 如果吞咽:立即寻求紧急医疗救助。 P318: 如果暴露或担心,请就医。 P319: 如果你感到不适,请寻求医疗帮助。
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





